Quantumup Posted - 2 days ago

$DAWN ICYDK (No PR AFAIK) $DAWN has Three Tovorafenib Presentations for the Upcoming 29th Annual Meeting and Education Day of the Society for Neuro-Oncology November 21-24, 2024 in Houston, TX. #SNO2024 https://virtual.oxfordabstracts.com/event/18018/submission/175 https://virtual.oxfordabstracts.com/event/18018/submission/198 https://virtual.oxfordabstracts.com/event/18018/submission/125 $eras

Quantumup Posted - 4 days ago

Jefferies initiated Erasca Inc ( $ERAS) at a Buy rating and a $6 price target. Jefferies told investors in its research note: "We see appeal in $ERAS's valuation supported by early but pot'ly best-in-class pan-RAS and pan-KRAS-targeted txs, given the massive market opty ( $RVMD mkt cap of ~$9B) and derisked MOA, based on data from $RVMD's RMC-6236. Add'ly, $ERAS preclin data look promising and are on-par/better than RMC-6236. ERAS is also in ph.III NRASmut melanoma w/ naporafenib + trametinib; although mkt opty could be smaller vs RAS, the study is derisked given prior ph.I&Il data." $nvs $mrk $dawn

OnTheBalance Posted - 1 week ago

$ERAS Consolidate and then UP ⬆️

NVDAMillionaire Posted - 1 week ago

$ERAS Erasca (ERAS): Pioneering the Fight Against RAS/MAPK-Driven Cancers https://beyondspx.com/article/erasca-eras-pioneering-the-fight-against-ras-mapk-driven-cancers

OnTheBalance Posted - 2 weeks ago

$ERAS next move above 3.50

OnTheBalance Posted - 2 weeks ago

@Chartwatcher1 the stop losses on this type of investment are easily manipulated by MMs whenever their "colleagues" want cheaper shares. It's a personal decision, but I do not allow them to steal my shares by using artificial price drops. What I do, is add more shares each time there is a foolish price drop... meaning take advantage of the stupidity. Stop losses might be ok on large liquid stocks of companies that have years of established earnings. Not for emerging bios. $ERAS

Chuck1991 Posted - 2 weeks ago

$ERAS

Doorkey Posted - 2 weeks ago

$ERAS $8

Chartwatcher1 Posted - 2 weeks ago

$ERAS breaking a descending triangle retracement = Bullish,, I am Long., always set a SL ! GL retailers!

OnTheBalance Posted - 2 weeks ago

$ERAS on its way past $3

OnTheBalance Posted - 10/29/24

$ERAS very bullish 😎

jimmieB Posted - 10/28/24

$ERAS Investors bailing on ERAS. RVMD is superior. Look you can have a superior monotherapy instead of some junk company that relies on a different drug (not owned by ERAS) to see any measurable efficacy.: https://finance.yahoo.com/news/revolution-medicines-presents-initial-data-081500732.html

Thestocktraderhubzee Posted - 10/28/24

WATCHLIST OCT 28 2024.. $VCSA Goldman Sachs Maintains Neutral on Vacasa, Lowers Price Target to $6.5 $ERAS Goldman Sachs Maintains Buy on Erasca, Raises Price Target to $3.5 $INFA JP Morgan Maintains Overweight on Informatica, Lowers Price Target to $34 $LUV JP Morgan Maintains Neutral on Southwest Airlines, Raises Price Target to $26 $IMNM Wedbush Reiterates Outperform on Immunome, Maintains $33 Price Target

Quantumup Posted - 10/27/24

BofA $CRSP, $DAWN, $EDIT, $ERAS, $EXAI

justiceforb_85 Posted - 10/25/24

$RVMD wondering if anyone here is also holding $ERAS? Appears to have some overlap with RAS-mutated cancers.

BucDan Posted - 10/24/24

$ERAS Looks like good news, but a hold and wait situation.

briefingcom Posted - 10/24/24

$ERAS: Erasca announces clinical progress for naporafenib and preclinical execution across the company’s RAS targeting franchise https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20241024080807ERAS&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

MoneyWise13 Posted - 10/24/24

$ERAS Great readout and updates! https://investors.erasca.com/news-releases/news-release-details/erasca-announces-strong-momentum-naporafenib-and-ras-targeting

MoneyWise13 Posted - 10/24/24

$ERAS 8:30am update begins. Should have a good feel of direction by market open.

lovemytattoos Posted - 1 month ago

$ERAS this could be a big week

OnTheBalance Posted - 1 month ago

$ERAS next leg up Ahead... investors with staying power who don't need day by day hand holding will do well.

Chuck1991 Posted - 1 month ago

$ERAS $MYNZ there you go !!!

OnTheBalance Posted - 1 month ago

$ERAS stupid spammer below 👿

Quantumup Posted - 1 month ago

Needham⬆️the PT on $DAWN to $33 was $32 and reits a Buy rating, after raising its ests for Ojemda based on a short MD survey (N=10)—🔑Takeaways in image: Needham remains confident of Ojemda growing to >$1B in 2030 in 1L/2L PLGG: $eras

OnTheBalance Posted - 1 month ago

$ERAS nice adding zone

MoneyWise13 Posted - 1 month ago

$ERAS Likely a slow move up just above $3 into data readout on the 24th

jimmieB Posted - 09/26/24

$KTTA eating the lunch of $ERAS

JB1991 Posted - 09/26/24

$ERAS getting in today. should easily get above 3

themacromindset Posted - 09/25/24

$ERAS $ERAS - Erasca to Present Preliminary SEACRAFT-1 Phase 1 Data for Naporafenib Plus Trametinib in RAS Q61X Mutant Solid Tumors as Oral Presentation at 36th EORTC-NCI-AACR Symposium

Stock_Titan Posted - 09/25/24

$ERAS Erasca to Present Preliminary SEACRAFT-1 Phase 1 Data for Naporafenib Plus Trametinib in RAS Q61X Mutant Solid Tumors as Oral Presentation at 36th EORTC-NCI-AACR Symposium https://www.stocktitan.net/news/ERAS/erasca-to-present-preliminary-seacraft-1-phase-1-data-for-c998nltrx540.html